Resources Contact Us Home
Pox virus comprising DNA sequences encoding CEA and B7 antigen

Image Number 10 for United States Patent #6780407.

Attenutated recombinant viruses containing DNA coding for a cytokine and/or a tumor associated antigen, as well as methods and compositions employing the viruses, are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The DNA can code for at least one of: human tumor necrosis factor; nuclear phosphoprotein p53, wiltype or mutant; human melanoma-associated antigen; IL-2; IFN.gamma.; IL-4; GMCSF; IL-12; B7; erb-B-2 and carcinoembryonic antigen. The recombinant viruses and gene products therefrom are useful for cancer therapy.

  Recently Added Patents
Method of fabricating solid electrolytic capacitor and solid electrolytic capacitor
File management apparatus and file management apparatus controlling method
Method and system for migrating object update messages through synchronous data propagation
Implementing state-of-the-art gate transistor, sidewall profile/angle control by tuning gate etch process recipe parameters
Headset systems and methods
Process of preparing functionalized polymers via enzymatic catalysis
Magnetoresistive shield with coupled lateral magnet bias
  Randomly Featured Patents
Method and system for order returns
Radial musical instrument stand spacer
Linkage apparatus having a mechanism for dampening vibrations
Communication interface for an electronic device
Radial bearing and bi-directional thrust bearing arrangement
Heating vest
Apparatus and method for securely fastening various pierced earring posts
Systems and methods for detecting pedestrians in the vicinity of a powered industrial vehicle
Mobile palm heel, wrist and forearm support for use with keyboards
Site-specific in situ generation of allicin using a targeted alliinase delivery system for the treatment of cancers, tumors, infectious diseases and other allicin-sensitive diseases